2004
DOI: 10.1021/ja049831l
|View full text |Cite
|
Sign up to set email alerts
|

New Poly(d-glucaramidoamine)s Induce DNA Nanoparticle Formation and Efficient Gene Delivery into Mammalian Cells

Abstract: In this report, four new poly(d-glucaramidoamine)s (1-4) have been designed to lower the toxicity of conventional polymeric nucleic acid delivery vehicles by incorporating a carbohydrate comonomer within a polyethylenimine (PEI)-like backbone. Polymers 1-4 were synthesized via polycondensation of esterified d-glucaric acid and four different amine-containing comonomers [diethylenetriamine (1), triethylenetetramine (2), tetraethylenepentamine (3), and pentaethylenehexamine (4)] in methanol. Viscometry and NMR s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

7
205
0

Year Published

2006
2006
2022
2022

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 132 publications
(213 citation statements)
references
References 28 publications
7
205
0
Order By: Relevance
“…A variety of biodegradable CPs such as poly(b-amino ester)s [14e17], poly[a-(4-aminobutyl)-L-glycolic acid] [18], poly(4-hydroxy-L-proline ester) [19], poly(D-glucaramidoamine) [20], cationic poly(a-hydroxy acid) [21], and cationic cyclodextrin [22] have been successfully synthesized and used in gene delivery studies. In addition to protecting therapeutic genes from nuclease degradation, synthetic design of CPs can be directed to optimize their biodegradability and improve their biocompatibility for repeated administration of gene-based therapies [23,24].…”
Section: Introductionmentioning
confidence: 99%
“…A variety of biodegradable CPs such as poly(b-amino ester)s [14e17], poly[a-(4-aminobutyl)-L-glycolic acid] [18], poly(4-hydroxy-L-proline ester) [19], poly(D-glucaramidoamine) [20], cationic poly(a-hydroxy acid) [21], and cationic cyclodextrin [22] have been successfully synthesized and used in gene delivery studies. In addition to protecting therapeutic genes from nuclease degradation, synthetic design of CPs can be directed to optimize their biodegradability and improve their biocompatibility for repeated administration of gene-based therapies [23,24].…”
Section: Introductionmentioning
confidence: 99%
“…Numerous polymers including polyethyleneimine (PEI) (Boussif et al, 1995;Shuai et al, 2003), polylysine (PLL) (Kang et al, 2005), dendrimers (Bayele et al, 2005;Braun et al, 2005;Marano et al, 2005), poly(2-(dimethylamino)ethyl methacrylate) (PDMAEMA) ( Van de Wetering et al, 1999), poly(ester amine)s (Zhong et al, 2005a,b), poly(D-glucaramidoamine) (Liu and Reineke, 2005;Liu and Reineke, 2006;Liu et al, 2004), and polysaccharideoligoamine based conjugates (Azzam et al, 2002;Yudovin-Farber et al, 2005) have been developed for gene delivery to other types of cells. For gene delivery to cardiomyocytes, polymer carriers must have low toxicity and be able to degrade into small molecules for exclusion from the cells.…”
Section: Viral Vectors Including Adenovirusmentioning
confidence: 99%
“…In polymer-facilitated gene delivery, the carrier polymers have to fulfill a cascade of several complex functions throughout the process of delivery, such as i) complexation and condensation of DNA, ii) translocation via the cell membrane, iii) liberation of the cargo DNA, and iv) delivery of DNA into the cell nucleus. [1] Among several other systems, [5,6] three major polymer classes predominate the literature since the beginning of polymerfacilitated DNA transport and delivery. It remains a surprising fact that these polymeric carriers are derived from rather simple polymers based on, for example, poly(L-lysine) (PLL), poly(ethylene imine)s (PEI), or chitosan.…”
Section: Introductionmentioning
confidence: 99%